NCT02789800 Patient-Centred Innovations for Persons With Multimorbidity - Quebec Status COMPLETED Phase NA
NCT02742597 Patient-Centred Innovations for Persons With Multimorbidity - Ontario Status COMPLETED Phase NA
NCT02730390 Study on the Efficacy and Safety of Oral Probucol Tablets in Patients With Hyperlipidemia - Post-Marketing Surveillance Status COMPLETED Phase N/A
NCT02676596 Study to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of K-312 in Healthy Subjects Status COMPLETED Phase PHASE1
NCT02670434 Safety and Efficacy Comparison Study of NK-104-CR (Controled Release) in Patients With Primary Hyperlipidemia or Mixed Dyslipidemia Status WITHDRAWN Phase PHASE3
NCT02659397 A Study Of Pharmacokinetics, Pharmacodynamics And Safety Of Adding ETC-1002 To Atorvastatin 80 mg Status COMPLETED Phase PHASE2
NCT02634034 A Comparison Study to Evaluate the Pharmacokinetics and Safety of NK-104-CR in Healthy Adult Volunteers Status COMPLETED Phase PHASE1
NCT02608242 PK Study of YH22189 FDC Compared to Combination of Telmisartan/Amlodipine and Rosuvastatin Status TERMINATED Phase PHASE1
NCT02582424 Safety and Efficacy of PDL-0101 in Patients With Hyperlipidemias: a Pilot Study. Status COMPLETED Phase NA
NCT02569814 A Study to Compare the Pharmacokinetics and Safety of a Fixed Dose Combination of Fimasartan/Amlodipine/Rosuvastatin Status COMPLETED Phase PHASE1
NCT02566187 A Study to Compare the Pharmacokinetics of Fimasartan/Atorvastatin Combination Tablet Status COMPLETED Phase PHASE1
NCT02532218 Evaluation of ARI-3037MO, to Suppress LDL Cholesterol in Patients With Dyslipidemia Status UNKNOWN Phase PHASE2
NCT02511418 Renal Hemodynamic Effects of the HMG-CoA Reductase Inhibitors in Normal Volunteers and in Patients With Chronic Renal Failure Status COMPLETED Phase NA
NCT02506920 Gender Dependent Difference in Lipemia After 6 x OFTT in Young Healthy Subjects Status COMPLETED Phase NA
NCT02458287 Efficacy, Safety, Tolerability And Actual Use Study Of Bococizumab And An Autoinjector (Pre-Filled Pen) In Subjects With Hyperlipidemia Or Dyslipidemia Status COMPLETED Phase PHASE3